VEDANTA BIOSCIENCES INC.

In News

Vedanta ‘significantly’ reduces headcount to fund lead bacteria cocktail program - Fierce Biotech

Fierce Biotech - Jan 16, 2026

Vedanta Downsizes by 20% After Phase II Stumble in Ulcerative Colitis - BioSpace

BioSpace - Aug 14, 2025

Convergent Therapeutics Taps Andrew Davis as Chief Business and Strategy Officer - Contract Pharma

Contract Pharma - Apr 29, 2026

Vedanta, PureTech’s microbiome startup, to cut staff after study setback - BioPharma Dive

BioPharma Dive - Aug 14, 2025

Vedanta Biosciences Announces the Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection Will Continue as Planned Following Protocol-Specified Interim Analysis - BioSpace

BioSpace - Apr 03, 2026

North America Human Microbiome Market Report 2026-2031, By Drug & Supplement, Disease, and Geo - MarketsandMarkets

MarketsandMarkets - Dec 15, 2025

Microbiome Therapeutics Market Size, Share | Forecast [2034] - Fortune Business Insights

Fortune Business Insights - May 18, 2026

Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint - Yahoo Finance

Yahoo Finance - Aug 13, 2025

Clostridium Difficile Infections Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight - Barchart

Barchart - Apr 07, 2026

Vedanta's live bacteria cocktail fails to reduce ulcerative colitis severity in phase 2 trial - Fierce Biotech

Fierce Biotech - Aug 13, 2025

Vedanta Biosciences Showcases Innovative Work on its Microbiome-based Therapeutics at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2026 Global Congress - BioSpace

BioSpace - Apr 10, 2026

21 Mass. life science companies must pay back tax breaks for failing to meet hiring goals - The Business Journals

The Business Journals - Oct 24, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment